Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sinerem-enhanced 3T MRI of carotid atherosclerotic plaques vs contrast-enhanced ultrasound
2008-005288-33Phase 2Terminated
- Sponsor
- GSK
- Start
- Jan 2009
- Modality
- Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, single-arm trial of ferumoxtran-10 in atherosclerotic disease and Carotid artery disease (CAD), sponsored by GSK. Primary endpoint: Primary. Started Jan 2009; status: terminated.
02
Drugs
ferumoxtran-10
03
Conditions
atherosclerotic diseaseCarotid artery disease (CAD)
Beyond the preview
Go deeper on 2008-005288-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005288-33.